Casdin Partners Master Fund, L.P. bought LAB
February 28, 2025 · Form 4 insider transaction
Casdin Partners Master Fund, L.P. bought 58,215 shares of Standard BioTools Inc. at $1.06 per share, a transaction worth $62.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
58,215
Price
$1.06
Total value
$62.0K
Role—
CompanyStandard BioTools Inc. (LAB)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 28, 2025
Filing dateMarch 4, 2025
Shares owned after2,806,470
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents Restricted Stock Units ("RSUs") that vest as to 25% on the last day of the last month of each fiscal quarter of 2025, subject to the Reporting Person's continued service through the applicable vesting date.; The RSUs were issued to the Reporting Person, who elected to take RSUs in lieu of $62,000 in cash compensation for services as a board member.; Includes RSUs.; The securities are owned directly by Eli Casdin.